论文部分内容阅读
一、国外医药及抗生素的最近动态目前,面临着竞争日趋激烈的非专利药物市场,医药工业更需要继续开发新抗生素品种,探索并推出新的方法来对付众多的耐药性细菌引起的感染,以达到有效的治疗。很多医药公司在寻找合作的伙伴和订立战略性协议以最大限度地取得开发新品种的机会,在企业中需要达到最高的研究效益,减少药物开发费用,这就使销售协议、技术转让、公司合并和收购等活动继续强化。以前如
I. Recent developments in foreign pharmaceuticals and antibiotics Currently, facing the increasingly fiercely generic drug market, the pharmaceutical industry needs to continue to develop new varieties of antibiotics, explore and introduce new methods to deal with infections caused by numerous drug-resistant bacteria. In order to achieve effective treatment. Many pharmaceutical companies are looking for cooperative partners and entering into strategic agreements to maximize the chances of developing new varieties. They need to achieve the highest research benefits in the enterprise and reduce drug development costs. This results in sales agreements, technology transfer, and company mergers. Activities such as acquisitions and acquisitions continue to strengthen. Previously